BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36378239)

  • 21. Radiotherapy target volume definition in newly diagnosed high grade glioma using
    Dissaux G; Dissaux B; Kabbaj OE; Gujral DM; Pradier O; Salaün PY; Seizeur R; Bourhis D; Ben Salem D; Querellou S; Schick U
    Radiother Oncol; 2020 Sep; 150():164-171. PubMed ID: 32580001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent functional and metabolic assessment of brain tumors using hybrid PET/MR imaging.
    Sacconi B; Raad RA; Lee J; Fine H; Kondziolka D; Golfinos JG; Babb JS; Jain R
    J Neurooncol; 2016 Apr; 127(2):287-93. PubMed ID: 26729270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis.
    Thust SC; Hassanein S; Bisdas S; Rees JH; Hyare H; Maynard JA; Brandner S; Tur C; Jäger HR; Yousry TA; Mancini L
    Eur Radiol; 2018 Sep; 28(9):3779-3788. PubMed ID: 29572636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
    Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
    Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra-lesional spatial correlation of static and dynamic FET-PET parameters with MRI-based cerebral blood volume in patients with untreated glioma.
    Göttler J; Lukas M; Kluge A; Kaczmarz S; Gempt J; Ringel F; Mustafa M; Meyer B; Zimmer C; Schwaiger M; Förster S; Preibisch C; Pyka T
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):392-397. PubMed ID: 27913827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy Target Volume Definition in Newly Diagnosed High-Grade Glioma Using 18F-FET PET Imaging and Multiparametric MRI: An Inter Observer Agreement Study.
    Dissaux B; Mazouz Fatmi D; Ognard J; Allard B; Keromnes N; Latreche A; Lepeuve A; Schick U; Bourbonne V; Ben Salem D; Dissaux G; Querellou S
    Tomography; 2022 Aug; 8(4):2030-2041. PubMed ID: 36006068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal changes in diffusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-grade gliomas.
    Rahm V; Boxheimer L; Bruehlmeier M; Berberat J; Nitzsche EU; Remonda L; Roelcke U
    J Nucl Med; 2014 Apr; 55(4):546-50. PubMed ID: 24566001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.
    Karavaeva E; Harris RJ; Leu K; Shabihkhani M; Yong WH; Pope WB; Lai A; Nghiemphu PL; Liau LM; Chen W; Czernin J; Cloughesy TF; Ellingson BM
    Mol Imaging Biol; 2015 Jun; 17(3):434-42. PubMed ID: 25465392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
    Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH
    Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.
    Rossi Espagnet MC; Romano A; Mancuso V; Cicone F; Napolitano A; Scaringi C; Minniti G; Bozzao A
    Br J Radiol; 2016 Oct; 89(1066):20160476. PubMed ID: 27505026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
    Verburg N; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Heimans JJ; Rozemuller AJM; Bruynzeel AME; Lagerwaard F; Vandertop WP; Boellaard R; Wesseling P; de Witt Hamer PC
    Neuro Oncol; 2020 Mar; 22(3):412-422. PubMed ID: 31550353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial spin labelling and diffusion-weighted imaging in paediatric brain tumours.
    Hales PW; d'Arco F; Cooper J; Pfeuffer J; Hargrave D; Mankad K; Clark C
    Neuroimage Clin; 2019; 22():101696. PubMed ID: 30735859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.
    Arvinda HR; Kesavadas C; Sarma PS; Thomas B; Radhakrishnan VV; Gupta AK; Kapilamoorthy TR; Nair S
    J Neurooncol; 2009 Aug; 94(1):87-96. PubMed ID: 19229590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
    Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
    Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
    Song PJ; Lu QY; Li MY; Li X; Shen F
    J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the variability and correlation between SUV and ADC parameters of head and neck cancers derived from simultaneous PET/MRI: A single-center study.
    Wongsa P; Nantasuk M; Singhnoi S; Pawano P; Jantarato A; Siripongsatian D; Lerdsirisuk P; Phonlakrai M
    J Appl Clin Med Phys; 2023 May; 24(5):e13928. PubMed ID: 36763489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG PET of common enhancing malignant brain tumors.
    Kosaka N; Tsuchida T; Uematsu H; Kimura H; Okazawa H; Itoh H
    AJR Am J Roentgenol; 2008 Jun; 190(6):W365-9. PubMed ID: 18492879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT with tumour grade and Ki-67 immunohistochemistry in glioma.
    Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
    Clin Neurol Neurosurg; 2014 Jan; 116():41-5. PubMed ID: 24309151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.